<kbd id="6pv673qe"></kbd><address id="r302zu9v"><style id="gdqswc00"></style></address><button id="q6ifbdt4"></button>

          Allergan lab

          A Different R&D Path

          Game-Changing Ideas & 革新

          生物制药创新生态系统发生了转变。全球制药公司那里以前发现,开发和提供新的产品从自己的实验室,今天创新的驱动源是从较小的生物技术和制药公司的到来,以及学术界。

          Given this shift in innovation origination, we have sought to follow a different R&D path than other companies.

          We embrace a model that defines our position in this new ecosystem – as a magnet for game-changing ideas and innovation. A large percentage of our pipeline is sourced by partnering with biotech companies, academia and other pharmaceutical companies globally. Through this approach, we drive strong R&D productivity by delivering innovative therapies that create long-term shared value for Allergan, for customers and for patients.

          推动创新的四个核心治疗领域

          Our R&D model has helped to build leadership in several therapeutic areas and drive the Company's long-term growth. Today, Allergan is rich with programs in development across four core therapeutic areas, with key candidates for global development in 医学美学 and Dermatology, 眼睛护理, 中枢神经系统 disorders and 肠胃病.

          Through this R&D strategy, we have added product opportunities from the innovation ecosystem across our key therapeutic areas. All programs enter our best-in-class product development and commercialization organization to build a sustainable portfolio that addresses unmet needs and aligns with our key therapeutic areas.

          We are committed to this strategy, and to continuing to invest significant dollars in R&D annually.

              <kbd id="3ezdlhny"></kbd><address id="4dyplydv"><style id="8g7i4n9r"></style></address><button id="bag45suy"></button>